Takeda Pharmaceutical Co Ltd (NYSE:TAK) Q1 2022 Earnings Conference Call July 30, 2021 6:00 AM ET Company Participants Christopher O'Reilly - Global Head, IR & Global Finance Christophe Weber - President & CEO Andrew Plump - President, Research & Development Constantine Saroukos - CFO Masato Iwasaki - Representative Director Julie Kim - President, Plasma-Derived Therapies Business Unit Ramona Sequeira - President, US Business Unit & Global Portfolio Commercialization Conference Call Participants Hidemaru Ya ...